|
1.
|
DR GreenGI EvanA matter of life and
deathCancer Cell11930200210.1016/S1535-6108(02)00024-7
|
|
2.
|
Y ZwangM OrenY YardenConsistency test of
the cell cycle: roles for p53 and EGR1Cancer
Res7210511054201210.1158/0008-5472.CAN-11-338222315347
|
|
3.
|
J CicenasM ValiusThe CDK inhibitors in
cancer research and therapyJ Cancer Res Clin
Oncol13714091418201110.1007/s00432-011-1039-421877198
|
|
4.
|
J PinesFour-dimensional control of the
cell cycleNat Cell Biol1E73E79199910.1038/1104110559915
|
|
5.
|
S OrtegaM MalumbresM BarbacidCyclin
D-dependent kinases, INK4 inhibitors and cancerBiochim Biophys
Acta16027387200211960696
|
|
6.
|
K MitraC WunderB RoysamG LinJ
Lippincott-SchwartzA hyperfused mitochondrial state achieved at
G1-S regulates cyclin E buildup and entry into S phaseProc Natl
Acad Sci USA1061196011965200910.1073/pnas.090487510619617534
|
|
7.
|
D CobrinikPocket proteins and cell cycle
controlOncogene2427962809200510.1038/sj.onc.120861915838516
|
|
8.
|
G LolliLN JohnsonCAK-cyclin-dependent
activating kinase: a key kinase in cell cycle control and a target
for drugs?Cell Cycle4572577200510.4161/cc.4.4.160715876871
|
|
9.
|
A SuttonR FreimanThe Cak1p protein kinase
is required at G1/S and G2/M in the budding yeast cell
cycleGenetics147577119979286668
|
|
10.
|
MR WallenfangG Seydouxcdk-7 is required
for mRNA transcription and cell cycle progression in
Caenorhabditis elegans embryosProc Natl Acad Sci
USA9955275532200210.1073/pnas.08261839911960010
|
|
11.
|
X AnSS NgD XieFunctional characterisation
of cell cycle-related kinase (CCRK) in colorectal cancer
carcinogenesisEur J
Cancer4617521761201010.1016/j.ejca.2010.04.00720466538
|
|
12.
|
S LarochelleJ PandurRP FisherHK SalzB
SuterCdk7 is essential for mitosis and for in vivo Cdk-activating
kinase activityGenes Dev12370381199810.1101/gad.12.3.3709450931
|
|
13.
|
H CleversWnt/beta-catenin signaling in
development and
diseaseCell127469480200610.1016/j.cell.2006.10.01817081971
|
|
14.
|
BT MacDonaldK TamaiX HeWnt/beta-catenin
signaling: components, mechanisms, and diseasesDev
Cell17926200910.1016/j.devcel.2009.06.01619619488
|
|
15.
|
W YangHX YanL ChenWnt/beta-catenin
signaling contributes to activation of normal and tumorigenic liver
progenitor cellsCancer
Res6842874295200810.1158/0008-5472.CAN-07-669118519688
|
|
16.
|
Y YingQ TaoEpigenetic disruption of the
WNT/beta-catenin signaling pathway in human
cancersEpigenetics4307312200910.4161/epi.4.5.937119633433
|
|
17.
|
H FengAS ChengDP TsangCell cycle-related
kinase is a direct androgen receptor-regulated gene that drives
beta-catenin/T cell factor-dependent hepatocarcinogenesisJ Clin
Invest12131593175201110.1172/JCI4596721747169
|
|
18.
|
P KaldisMJ SolomonAnalysis of CAK
activities from human cellsEur J
Biochem26742134221200010.1046/j.1432-1327.2000.01455.x10866826
|
|
19.
|
L WohlboldS LarochelleJC LiaoG LivshitsJ
SingerKM ShokatRP FisherThe cyclin-dependent kinase (CDK) family
member PNQALRE/CCRK supports cell proliferation but has no
intrinsic CDK-activating kinase (CAK) activityCell
Cycle5546554200610.4161/cc.5.5.254116552187
|
|
20.
|
Y LiuC WuK Galaktionovp42, a novel
cyclin-dependent kinase-activating kinase in mammalian cellsJ Biol
Chem27945074514200410.1074/jbc.M30999520014597612
|
|
21.
|
SS NgYT CheungXM AnCell cycle-related
kinase: a novel candidate oncogene in human glioblastomaJ Natl
Cancer Inst99936948200710.1093/jnci/djm01117565152
|
|
22.
|
H QiuH DaiK JainR ShahC HongJ PainB TianDE
VatnerSF VatnerC DepreCharacterization of a novel cardiac isoform
of the cell cycle-related kinase that is regulated during heart
failureJ Biol
Chem2832215722165200810.1074/jbc.M71045920018508765
|
|
23.
|
GQ WuD XieGF YangYJ LiaoSJ MaiHX DengJ
SzeXY GuanYX ZengMC LinHF KungCell cycle-related kinase supports
ovarian carcinoma cell proliferation via regulation of cyclin D1
and is a predictor of outcome in patients with ovarian carcinomaInt
J Cancer12526312642200910.1002/ijc.2463019672860
|
|
24.
|
Y YangY HuHY GuN LuW LiuQ QiL ZhaoXT
WangQD YouQL GuoOroxylin A induces G2/M phase cell-cycle arrest via
inhibiting Cdk7-mediated expression of Cdc2/p34 in human gastric
carcinoma BGC-823 cellsJ Pharm
Pharmacol6014591463200810.1211/jpp.60.11.000618957166
|
|
25.
|
J YuQL GuoQD YouL ZhaoHY GuY YangHW ZhangZ
TanX WangGambogic acid-induced G2/M phase cell-cycle arrest via
disturbing CDK7-mediated phosphorylation of CDC2/p34 in human
gastric carcinoma BGC-823
cellsCarcinogenesis28632638200710.1093/carcin/bgl16817012222
|
|
26.
|
V KrystofS UldrijanCyclin-dependent kinase
inhibitors as anticancer drugsCurr Drug
Targets11291302201010.2174/13894501079071195020210754
|
|
27.
|
J Węsierska-GądekM MaurerPromotion of
apoptosis in cancer cells by selective purine-derived
pharmacological CDK inhibitors: one outcome, many mechanismsCurr
Pharm Des17256271201121348827
|
|
28.
|
JM EglyF CoinA history of TFIIH: two
decades of molecular biology on a pivotal transcription/repair
factorDNA Repair
(Amst)10714721201110.1016/j.dnarep.2011.04.02121592869
|
|
29.
|
SA PatelMC SimonFunctional analysis of the
Cdk7.cyclin H.Mat1 complex in mouse embryonic stem cells and
embryosJ Biol
Chem2851558715598201010.1074/jbc.M109.08168720231280
|
|
30.
|
K Glover-CutterS LarochelleB EricksonC
ZhangK ShokatRP FisherDL BentleyTFIIH-associated Cdk7 kinase
functions in phosphorylation of C-terminal domain Ser7 residues,
promoter-proximal pausing, and termination by RNA polymerase IIMol
Cell Biol2954555464200910.1128/MCB.00637-0919667075
|
|
31.
|
RP FisherSecrets of a double agent: CDK7
in cell-cycle control and transcriptionJ Cell
Sci11851715180200510.1242/jcs.0271816280550
|
|
32.
|
S LarochelleKA MerrickME TerretL
WohlboldNM BarbozaC ZhangKM ShokatPV JallepalliRP
FisherRequirements for Cdk7 in the assembly of Cdk1/cyclin B and
activation of Cdk2 revealed by chemical genetics in human cellsMol
Cell25839850200710.1016/j.molcel.2007.02.00317386261
|
|
33.
|
P PillaiS DesaiR PatelM SajanR FareseD
OstrovM Acevedo-DuncanA novel PKC-iota inhibitor abrogates cell
proliferation and induces apoptosis in neuroblastomaInt J Biochem
Cell Biol43784794201110.1016/j.biocel.2011.02.00221315177
|
|
34.
|
L BicaJ MeyerowitzSJ ParkerA CaragounisT
DuBM PatersonKJ BarnhamPJ CrouchAR WhitePS DonnellyCell cycle
arrest in cultured neuroblastoma cells exposed to a
bis(thiosemicarbazonato) metal
complexBiometals24117133201110.1007/s10534-010-9380-720931265
|
|
35.
|
RP FisherDO MorganA novel cyclin
associates with MO15/CDK7 to form the CDK-activating
kinaseCell78713724199410.1016/0092-8674(94)90535-58069918
|
|
36.
|
G LolliLN JohnsonRecognition of Cdk2 by
Cdk7Proteins6710481059200710.1002/prot.2137017373709
|
|
37.
|
H NagaharaSA EzhevskyAM Vocero-AkbaniP
KaldisMJ SolomonSF DowdyTransforming growth factor beta targeted
inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes
by inhibition of Cdk2 activating kinase activityProc Natl Acad Sci
USA961496114966199910.1073/pnas.96.26.1496110611320
|
|
38.
|
Z FuKA LarsonRK ChittaIdentification of
yin-yang regulators and a phosphorylation consensus for male germ
cell-associated kinase (MAK)-related kinaseMol Cell
Biol2686398654200610.1128/MCB.00816-0616954377
|
|
39.
|
RM MarshallX GranaMechanisms controlling
CDK9 activityFront Biosci1125982613200610.2741/199416720337
|
|
40.
|
WH YangJH HeatonH BrevigS MukherjeeJA
Iñiguez-LluhíGD HammerSUMOylation inhibits SF-1 activity by
reducing CDK7-mediated serine 203 phosphorylationMol Cell
Biol29613625200910.1128/MCB.00295-0819015234
|
|
41.
|
UM SachdevaJM O'BrienUnderstanding pRb:
toward the necessary development of targeted treatments for
retinoblastomaJ Clin
Invest122425434201210.1172/JCI5711422293180
|
|
42.
|
V KolupaevaC BasilicoOverexpression of
cyclin E/CDK2 complexes overcomes FGF-induced cell cycle arrest in
the presence of hypophosphorylated Rb proteinsCell
CycleJul.12012(E-pub ahead of print).
|
|
43.
|
P MeraldiJ LukasAM FryJ BartekEA
NiggCentrosome duplication in mammalian somatic cells requires E2F
and Cdk2-cyclin ANat Cell Biol18893199910.1038/1005410559879
|
|
44.
|
M StamatakosV PallaI KaraiskosK
XiromeritisI AlexiouI PaterasK KontzoglouCell cyclins: triggering
elements of cancer or not?World J Surg
Oncol8111201010.1186/1477-7819-8-11121176227
|
|
45.
|
RA WeinbergThe retinoblastoma protein and
cell cycle
controlCell81323330199510.1016/0092-8674(95)90385-27736585
|
|
46.
|
L XiaD RobinsonAH MaHC ChenF WuY QiuHJ
KungIdentification of human male germ cell-associated kinase, a
kinase transcriptionally activated by androgen in prostate cancer
cellsJ Biol Chem2773542235433200210.1074/jbc.M20394020012084720
|
|
47.
|
F DesmotsHR RussellY LeeK BoydPJ
McKinnonThe reaper-binding protein scythe modulates apoptosis and
proliferation during mammalian developmentMol Cell
Biol251032910337200510.1128/MCB.25.23.10329-10337.200516287848
|
|
48.
|
F DesmotsHR RussellD MichelPJ
McKinnonScythe regulates apoptosis-inducing factor stability during
endoplasmic reticulum stress-induced apoptosisJ Biol
Chem28332643271200810.1074/jbc.M706419200
|
|
49.
|
R MinamiM ShimadaH YokosawaH
KawaharaScythe regulates apoptosis through modulating
ubiquitin-mediated proteolysis of the Xenopus elongation
factor XEF1AOBiochem J405495501200710.1042/BJ2006188617428197
|
|
50.
|
T GoldenM SwingleRE HonkanenThe role of
serine/threonine protein phosphatase type 5 (PP5) in the regulation
of stress-induced signaling networks and cancerCancer Metastasis
Rev27169178200810.1007/s10555-008-9125-z
|
|
51.
|
BM HamH JayachandranF YangNovel Ser/Thr
protein phosphatase 5 (PP5) regulated targets during DNA damage
identified by proteomics analysisJ Proteome
Res9945953201010.1021/pr900820720039704
|
|
52.
|
AH MaL XiaSJ DesaiDL BoucherY GuanHM
ShihXB ShiRW deVere WhiteHW ChenCG TepperHJ KungMale germ
cell-associated kinase, a male-specific kinase regulated by
androgen, is a coactivator of androgen receptor in prostate cancer
cellsCancer
Res6684398447200610.1158/0008-5472.CAN-06-163616951154
|
|
53.
|
SP BalkKE KnudsenAR, the cell cycle, and
prostate cancerNucl Recept Signal6e001200818301781
|
|
54.
|
M KalraJ MayesS AssefaAK KaulR KaulRole of
sex steroid receptors in pathobiology of hepatocellular
carcinomaWorld J
Gastroenterol1459455961200810.3748/wjg.14.594518932272
|
|
55.
|
N AminE VincanThe Wnt signaling pathways
and cell adhesionFront Biosci17784804201210.2741/3957
|
|
56.
|
RS TaraporeIA SiddiquiH MukhtarModulation
of Wnt/beta-catenin signaling pathway by bioactive food
componentsCarcinogenesis33483491201210.1093/carcin/bgr30522198211
|
|
57.
|
D KimelmanW Xubeta-catenin destruction
complex: insights and questions from a structural
perspectiveOncogene2574827491200610.1038/sj.onc.121005517143292
|
|
58.
|
DM RobertsMI PronobisJS PoultonJD
WaldmannEM StephensonS HannaM PeiferDeconstructing the β-catenin
destruction complex: mechanistic roles for the tumor suppressor APC
in regulating Wnt signalingMol Biol Cell22184518632011
|
|
59.
|
A KikuchiH YamamotoA SatoS MatsumotoNew
insights into the mechanism of Wnt signaling pathway activationInt
Rev Cell Mol
Biol2912171201110.1016/B978-0-12-386035-4.00002-122017973
|
|
60.
|
CY LoganR NusseThe Wnt signaling pathway
in development and diseaseAnnu Rev Cell Dev
Biol20781810200410.1146/annurev.cellbio.20.010403.11312615473860
|
|
61.
|
S WhittakerR MaraisAX ZhuThe role of
signaling pathways in the development and treatment of
hepatocellular
carcinomaOncogene2949895005201010.1038/onc.2010.23620639898
|
|
62.
|
X TanU ApteA MicsenyiE KotsagrelosJH LuoS
RanganathanDK MongaA BellGK MichalopoulosSP MongaEpidermal growth
factor receptor: a novel target of the Wnt/beta-catenin pathway in
liverGastroenterology129285302200510.1053/j.gastro.2005.04.01316012954
|
|
63.
|
JL BuescherCJ PhielA noncatalytic domain
of glycogen synthase kinase-3 (GSK-3) is essential for activityJ
Biol Chem28579577963201010.1074/jbc.M109.09160320080974
|
|
64.
|
P Uysal-OnganerRM KyptaWnt11 in 2011 - the
regulation and function of a non-canonical WntActa Physiol
(Oxf)2045264201210.1111/j.1748-1716.2011.02297.x21447091
|
|
65.
|
V GordonS BhadelW WunderlichCDK9 regulates
AR promoter selectivity and cell growth through serine 81
phosphorylationMol
Endocrinol2422672280201010.1210/me.2010-023820980437
|
|
66.
|
JK KimJA DiehlNuclear cyclin D1: an
oncogenic driver in human cancerJ Cell
Physiol220292296200910.1002/jcp.2179119415697
|
|
67.
|
EA MusgroveCE CaldonJ BarracloughA StoneRL
SutherlandCyclin D as a therapeutic target in cancerNat Rev
Cancer11558572201110.1038/nrc309021734724
|
|
68.
|
AR NebredaCDK activation by non-cyclin
proteinsCurr Opin Cell
Biol18192198200610.1016/j.ceb.2006.01.00116488127
|
|
69.
|
T AbbasA DuttaCDK2-activating kinase
(CAK): more questions than answersCell
Cycle511231124200610.4161/cc.5.10.281916687928
|
